Imaging metalloproteinase activity in vivo

Nature Medicine

Volumn 7, Issue 6, 2001, Pages 655-656

  Zucker, Stanley ^a,b   Cao, Jian ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE INHIBITOR; METALLOPROTEINASE;

DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; EVALUATION; IMAGING SYSTEM; IN VIVO STUDY; NEAR INFRARED FLUORESCENCE IMAGING; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TECHNIQUE;

ANIMALS; ANTINEOPLASTIC AGENTS; DIAGNOSTIC IMAGING; EXTRACELLULAR MATRIX PROTEINS; FLUORESCENCE; HUMANS; MATRIX METALLOPROTEINASES; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; ORGANIC CHEMICALS; SERINE ENDOPEPTIDASES;

EID: 0034953171     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/89016     Document Type: Short Survey

References (11)

1. Cancer cell invasion and metastasis
2. Changing views of the role of matrix metalloproteinases in metastasis
3. In vivo molecular target assessment of matrix metalloproteinase inhibition
4. Matrix metalloproteinase
5. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
6. Matrix metalloproteinases: Biologic activity and clinical implications
7. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
8. The human tumor cell-derived collagenase stimulating factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily
9. Tumorigenic potential of extracellular matrix metalloproteinase inducer (EMMPRIN)
10. Broad antitumor and angiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials
11. Effect of angiogenesis inhibitors on multistage carcinogenesis in mice